Ooma, Inc. (OOMA)

NYSEInformation TechnologyTelecommunications ServicesSnapshot 2026-10-23

$19.77+0.41%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Ooma, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-1.1%

+10% or more+5%0%−5%−10% or less

1.52 → 1.50 EPS · FY ending Jan 31, 2028 · 5 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 5 to 5; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-10-31
Revenue	—	84.02M
EPS	—	0.343
Annual ending 2027-01-31
Revenue	—	332.92M
EPS	—	1.369
Annual ending 2028-01-31
Revenue	—	348.95M
EPS	—	1.501

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Achieve GAAP EPS of $0.37-$0.42 for FY 2027	A primary condition in Ooma, Inc.'s published investment case. The stated target is $0.37-$0.42 EPS.	Intact	EPS falls below $0.37 in FY 2027	Diluted EPS: $0.10 per share FY2027-Q2; GAAP. Published target: $0.37-$0.42 EPS. Target period is not explicitly aligned with this observation. Source published Sep 4, 20260.1 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2027-Q2 · Period ending Jul 31, 2026 Source: company_financial_results. Reference: 08d3c028-4a0b-4ea1-9ad0-de82b90f8367. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. GAAP diluted EPS rose from $0.04 in 2026-Q2 to $0.10 in 2027-Q2, a 150% increase year-over-year. Management's fiscal 2027 GAAP EPS guidance remains at $0.37 to $0.42, indicating progress and delivery on this priority. Delivery assessment Oct 24, 2026
Achieve non-GAAP net income of $37.5M-$39M for FY 2027	A supporting condition in Ooma, Inc.'s published investment case. The stated target is $37.5M-$39M non-GAAP net income.	Intact	Non-GAAP net income falls below $37.5M in FY 2027	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Non-GAAP net income increased from $6.45 million in 2026-Q2 to $10.2 million in 2027-Q2, a 58% rise year-over-year. Fiscal 2027 guidance for non-GAAP net income remains at $37.5 million to $39 million, showing management is delivering on this target. Delivery assessment Oct 24, 2026
Increase revenue to $326M-$328.5M for FY 2027	A primary condition in Ooma, Inc.'s published investment case. The stated target is $326M-$328.5M total revenue.	Intact	Revenue falls below $326M in FY 2027	Revenue: $83.228M FY2027-Q2; GAAP. Published target: $326M-$328.5M total revenue. Target period is not explicitly aligned with this observation. Source published Sep 4, 202683,228,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2027-Q2 · Period ending Jul 31, 2026 Source: company_financial_results. Reference: 08d3c028-4a0b-4ea1-9ad0-de82b90f8367. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Revenue grew from $66.4 million in 2026-Q2 to $83.2 million in 2027-Q2, a 25% increase year-over-year. Management's fiscal 2027 revenue guidance remains in the $326 million to $328.5 million range, indicating delivery and on-track trajectory. Delivery assessment Oct 24, 2026
Maintain valuation below peer median PE of 38x	Its valuation is cheap compared to peers with a strong market position.	Intact	PE rises above 38x without earnings growth	P/E (TTM): 16.75x As of 2026-10-23; trailing twelve months. The target timing and basis require a separate assessment. Market data as of Oct 23, 202616.7542 ratio · calculatedLast status assessment Oct 24, 2026 Measurement source consolidated · TTM valuation Period ending Oct 23, 2026 Source: mart.stock_valuation_daily. Reference: OOMA:2026-10-23. Source status: canonical calculation. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-01-31 · fmp

FY2028 EPS$1.50

$1.49 → $1.50 · observed estimates

FY2028 revenue$0.35B

$0.34B → $0.35B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$1.49	$342,515,143	5 / 6
2026-07-25	$1.49	$342,515,143	5 / 6
2026-07-26	$1.49	$342,515,143	5 / 6
2026-07-27	$1.49	$342,515,143	5 / 6
2026-07-28	$1.49	$342,515,143	5 / 6
2026-07-29	$1.49	$342,515,143	5 / 6
2026-07-30	$1.49	$342,515,143	5 / 6
2026-07-31	$1.49	$342,515,143	5 / 6
2026-08-01	$1.49	$342,515,143	5 / 6
2026-08-02	$1.49	$342,515,143	5 / 6
2026-08-03	$1.49	$342,515,143	5 / 6
2026-08-04	$1.49	$342,515,143	5 / 6
2026-08-05	$1.49	$342,515,143	5 / 6
2026-08-06	$1.49	$342,515,143	5 / 6
2026-08-07	$1.49	$342,515,143	5 / 6
2026-08-08	$1.49	$342,515,143	5 / 6
2026-08-09	$1.49	$342,515,143	5 / 6
2026-08-10	$1.49	$342,515,143	5 / 6
2026-08-12	$1.49	$342,515,143	5 / 6
2026-08-13	$1.49	$342,515,140	7 / 7
2026-08-14	$1.49	$342,515,143	5 / 6
2026-08-15	$1.49	$342,515,143	5 / 6
2026-08-16	$1.49	$342,515,143	5 / 6
2026-08-17	$1.49	$342,515,143	5 / 6
2026-08-18	$1.49	$342,515,143	5 / 6
2026-08-19	$1.49	$342,515,143	5 / 6
2026-08-20	$1.49	$342,510,000	5 / 6
2026-08-21	Unavailable	$342,510,000	4 / 6
2026-08-22	Unavailable	$342,510,000	4 / 5
2026-08-23	Unavailable	$342,510,000	4 / 5
2026-08-24	Unavailable	$342,510,000	4 / 5
2026-08-25	Unavailable	$342,510,000	4 / 5
2026-08-26	Unavailable	$342,510,000	4 / 5
2026-08-27	Unavailable	$342,510,000	4 / 5
2026-08-28	Unavailable	$342,510,000	4 / 5
2026-08-29	Unavailable	$348,957,714	4 / 5
2026-08-30	Unavailable	$348,957,714	4 / 5
2026-08-31	Unavailable	$348,957,714	4 / 5
2026-09-01	Unavailable	$348,957,714	4 / 5
2026-09-02	Unavailable	$348,957,714	4 / 5
2026-09-03	$1.52	$348,957,714	5 / 6
2026-09-04	$1.52	$348,957,714	5 / 6
2026-09-05	$1.52	$348,957,714	5 / 6
2026-09-06	$1.52	$348,957,714	5 / 6
2026-09-07	$1.52	$348,957,714	5 / 6
2026-09-08	$1.52	$348,957,714	5 / 6
2026-09-09	$1.52	$348,957,714	5 / 6
2026-09-10	$1.52	$348,957,714	5 / 6
2026-09-11	$1.52	$348,957,714	5 / 6
2026-09-12	$1.52	$348,957,714	5 / 6
2026-09-13	$1.52	$348,957,714	5 / 6
2026-09-14	$1.52	$348,957,714	5 / 6
2026-09-15	$1.52	$348,957,714	5 / 6
2026-09-16	$1.52	$348,957,714	5 / 6
2026-09-17	$1.52	$348,957,714	5 / 6
2026-09-18	$1.52	$348,957,714	5 / 6
2026-09-19	$1.52	$348,957,714	5 / 6
2026-09-20	$1.52	$348,957,714	5 / 6
2026-09-21	$1.52	$348,957,714	5 / 6
2026-09-22	$1.52	$348,957,714	5 / 6
2026-09-23	$1.52	$348,957,714	5 / 6
2026-09-24	$1.52	$348,957,714	5 / 6
2026-09-25	$1.52	$348,957,714	5 / 6
2026-09-26	$1.52	$348,957,714	5 / 6
2026-09-27	$1.52	$348,957,714	5 / 6
2026-09-28	$1.52	$348,957,714	5 / 6
2026-09-29	$1.52	$348,957,714	5 / 6
2026-09-30	$1.52	$348,957,714	5 / 6
2026-10-01	$1.52	$348,954,429	5 / 6
2026-10-02	$1.50	$348,954,429	5 / 6
2026-10-03	$1.50	$348,954,429	5 / 6
2026-10-04	$1.50	$348,954,429	5 / 6
2026-10-05	$1.50	$348,954,429	5 / 6
2026-10-06	$1.50	$348,954,429	5 / 6
2026-10-07	$1.50	$348,954,429	5 / 6
2026-10-08	$1.50	$348,954,429	5 / 6
2026-10-09	$1.50	$348,954,429	5 / 6
2026-10-10	$1.50	$348,954,429	5 / 6
2026-10-11	$1.50	$348,954,429	5 / 6
2026-10-12	$1.50	$348,954,429	5 / 6
2026-10-13	$1.50	$348,954,429	5 / 6
2026-10-14	$1.50	$348,954,429	5 / 6
2026-10-15	$1.50	$348,954,429	5 / 6
2026-10-16	$1.50	$348,954,429	5 / 6
2026-10-17	$1.50	$348,954,429	5 / 6
2026-10-18	$1.50	$348,954,429	5 / 6
2026-10-19	$1.50	$348,954,429	5 / 6
2026-10-20	$1.50	$348,954,429	5 / 6
2026-10-21	$1.50	$348,954,429	5 / 6
2026-10-22	$1.50	$348,954,429	5 / 6
2026-10-23	$1.50	$348,954,429	5 / 6
2026-10-24	$1.50	$348,954,429	5 / 6

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	6	1
2026-06-01	6	1
2026-07-01	6	1
2026-08-01	6	1
2026-09-01	6	1
2026-10-01	6	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 6 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 25–Oct 24 · 1 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

B.Riley FinancialSep 30

$27.00New observation · no comparable prior

$0$14.85$29.70

0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Achieve GAAP EPS of $0.37-$0.42 for FY 2027Diluted EPS: $0.10 per share
Achieve non-GAAP net income of $37.5M-$39M for FY 2027Direct metric needs a verified mapping
Increase revenue to $326M-$328.5M for FY 2027Revenue: $83.228M
Maintain valuation below peer median PE of 38xP/E (TTM): 16.75x

Next proof point

Dec 14, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.4%Typical daily move · historical

Downside history

-15.8%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Ooma, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

OOMA is a growth-oriented business with improving recent results, but it is not yet consistently profitable under GAAP, or standard accounting rules. Its long-term thesis is intact, with management’s main fiscal 2027 goals on track; the evidence points to a smaller company with elevated risk rather than a proven durable compounder.

What's priced into Ooma, Inc.

The valuation evidence is mixed: one measure says OOMA is cheap versus peers, while another shows a 56% premium to peers, and the overall value assessment is expensive. The priced-in tag is justified, with low fragility, but the expectations gap is negative, suggesting expectations are not clearly a source of extra support; valuation also rose recently.

What the fundamentals likely do

Near-term results have been strong: the latest reported quarter showed revenue up 25% year over year and non-GAAP net income up 58%, while management kept its fiscal 2027 guidance in place. Management also reported higher GAAP diluted earnings per share, and all three stated goals remain on track; however, the business is still classified as loss-making, and a future guidance cut is a key risk despite a low near-term miss estimate.

What Ooma, Inc. hinges on

Over the next several quarters, the thesis depends on OOMA continuing to deliver its revenue, non-GAAP net income, and GAAP earnings goals without cutting guidance. A guidance cut would weaken the case, while the evidence also identifies lower interest rates and stronger technology-sector momentum as possible tailwinds; neither is assured.